New York S06422 allows prescription labels for certain hormone therapies to list the dispensing practice instead of the prescriber and requires.

New York S06422 amends the education and public health laws to allow prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy to include the name of the dispensing practice instead of the prescriber. The bill also mandates that health care prescribers inform patients if the name or address of the prescribing health care practice is included on the prescription label instead of the prescriber's name. This change applies to treatments for gender dysphoria.

New York S06422 allows prescription labels for certain hormone therapies to list the dispensing practice instead of the prescriber and requires.

New York S06422 amends the education and public health laws to allow prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy to include the name of the dispensing practice instead of the prescriber. The bill also mandates that health care prescribers inform patients if the name or address of the prescribing health care practice is included on the prescription label instead of the prescriber's name. This change applies to treatments for gender dysphoria.